RIKEN Center for Integrative Medical Sciences

Company

Related News

AI-Driven Biomarker Identifies High-Risk Liver Cancer Patients Before Tumor Formation

Feb 18, 2026

Researchers at RIKEN Center for Integrative Medical Sciences in Japan have developed a machine-learning algorithm that predicts hepatocellular carcinoma risk by analyzing the MYCN protein and tumor-promoting microenvironments in liver tissue before malignancy manifests.

AI and Machine Learning Advance Cancer Biomarker Discovery and Treatment Strategies

Feb 18, 2026

Researchers develop machine-learned biomarker predicting liver cancer risk with 93% accuracy, while AI-driven drug repurposing offers faster, cost-effective alternatives to address cancer survivorship gaps.

Related Clinical Trials

NCT ID	Title	Status	Phase
NCT07205913	Gut Microbiota, Diet-INDuced Obesity and Type 2 Diabetes in New Caledonia - MIND	NOT_YET_RECRUITING